Abstract
The ethnic variation in the GGN and CAG microsatellites of the androgen receptor (AR) gene suggests their role in the substantial racial difference in prostate cancer risk. Hence, we performed a case-control study to assess whether GGN repeats independently or in combination with CAG repeats were associated with prostate cancer risk in South Indian men. The repeat lengths of the AR gene determined by Gene scan analysis, revealed that men with GGN repeats ≤21 had no significant risk compared to those with >21 repeats (OR 0.91 at 95% CI-0.52–1.58). However, when CAG repeats of our earlier study was combined with the GGN repeat data, the cases exhibited significantly higher frequency of the haplotypes CAG ≤19/GGN ≤21 (OR-5.2 at 95% CI-2.17–12.48, P < 0.001) and CAG ≤19/GGN > 21(OR-6.9 at 95%CI-2.85–17.01, P < 0.001) compared to the controls. No significant association was observed between GGN repeats and prostate-specific antigen levels and the age at diagnosis. Although a trend of short GGN repeats length in high-grade was observed, it was not significant (P = 0.09). Overall, our data reveals that specific GGN/CAG haplotypes (CAG ≤19/GGN ≤21 and CAG ≤19/GGN > 21) of AR gene increase the risk of prostate cancer and thus could serve as susceptibility marker for prostate cancer in South Indian men.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chamberlain N, Driver E, Miesfeld R (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 22:3181–3186
Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB, Xu J (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 110:122–129
Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, Di Tommaso D, Goodman G (2002) Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1033–1040
Cicek MS, Conti DV, Curran A, Phillippa JN, Paris PL, Graham C, John SW (2004) Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate 59:69–76
Coetzee GA, Ross RK (1994) Re: prostate cancer and the androgen receptor. J Nat Cancer Inst 86:872–873
Correa-Cerro L, Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G, Cussenot O, Kraus P, Just W, Paiss T, Cantu JM, Vogel W (1999) (CAG) n and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population. Eur J Hum Genet 7:357–362
Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338–362
Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241–253
Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, Dearnaley DP, Eeles RA (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 84:458–465
Forrest MS, Edwards SM, Houlston R, Kote Jarai Z, Key T, Allen N, Knowles MA, Turner F, Ardern Jones A, Murkin A, Williams S, Oram R, CR-UK/BPG UK prostate cancer study collaborators et al (2005) Association between hormonal genetic polymorphisms and early onset prostate cancer. Prostate Cancer Prostatic Dis 8:95–102
Gao T, Marcelli M, McPhaul MJ (1996) Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 59:9–20
Gronberg H (2003) Prostate cancer epidemiology. Lancet 361:859–864
Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER (1997). Androgen receptor variants with short glutamine or glycine repeats may identify unique sub populations of men with prostate cancer. Clin Cancer Res 3:1599–1608
Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C (2000) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60:5111–5116
Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937–1940
Janne OA, Palvimo JJ, Kallio P, Mehto M (1993) Androgen receptor and mechanism of androgen action. Ann Med 25:83–89
Jenster G, Ruiter PE, Van der Korput HA, Kuiper GG, Trapman J, Brinkmann AO (1994) Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33:14064–14072
Krishnaswamy V, Kumarasamy T, Venkatesan V, Shroff S, Jayanth VR, Paul SFD (2006) South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer. J Hum Genet 51:254–257
Lu S, Tsai SY, Tsai MJ (1997) Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI P16 genes. Cancer Res 57:4511–4516
Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA (2001) Polymorphic repeats in the androgen receptor gene in high-risk sibships. Prostate 48:200–205
Mishra DK, Thangaraj K, Mandhani A, Kumar A, Mittal RD (2005) Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 68:55–60
Nwosu V, Carpten J, Trent JM, Sheriden R (2001) Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 10:2313–2318
Patrizio P, Leonard DGB, Chen K-L, Hernandez-Ayup S, Trounson AO (2001) Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl 22:444–448
Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW (1998) The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomark Prev 7:379–384
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York 9.17–9.19
Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57:1194–1198
Acknowledgments
We thank the Director, Centre for Cellular and Molecular Biology (CCMB), Hyderabad, for providing facilities to perform the experiments. K.V. acknowledges the Council of Scientific and Industrial Research (CSIR), New Delhi for providing Senior Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vijayalakshmi, K., Thangaraj, K., Rajender, S. et al. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men. J Hum Genet 51, 998–1005 (2006). https://doi.org/10.1007/s10038-006-0051-z
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-006-0051-z
Keywords
This article is cited by
-
Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis
Scientific Reports (2017)
